Hodgkin Lymphoma Global Clinical Trials Review, H2, 2013

News provided by

Dec 19, 2013, 01:27 ET

NEW YORK, Dec. 19, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Hodgkin Lymphoma Global Clinical Trials Review, H2, 2013

http://www.reportlinker.com/p0739453/Hodgkin-Lymphoma-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

Hodgkin Lymphoma Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, "Hodgkin Lymphoma Global Clinical Trials Review, H2, 2013" provides data on the Hodgkin Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hodgkin Lymphoma . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hodgkin Lymphoma . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hodgkin Lymphoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Hodgkin Lymphoma 25
Subjects Recruited Over a Period of Time 33
Prominent Sponsors 34
Top Companies Participating in Hodgkin Lymphoma Therapeutics Clinical Trials 36
Prominent Drug Comparison 38
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
Seattle Genetics, Inc. 39
Clinical Trial Overview of Seattle Genetics, Inc. 39
Takeda Pharmaceutical Company Limited 41
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 41
Novartis AG 43
Clinical Trial Overview of Novartis AG 43
Amgen Inc. 45
Clinical Trial Overview of Amgen Inc. 45
Sanofi 47
Clinical Trial Overview of Sanofi 47
Bristol-Myers Squibb Company 49
Clinical Trial Overview of Bristol-Myers Squibb Company 49
Celgene Corporation 50
Clinical Trial Overview of Celgene Corporation 50
Merck & Co., Inc. 51
Clinical Trial Overview of Merck & Co., Inc. 51
Pharmacyclics, Inc. 52
Clinical Trial Overview of Pharmacyclics, Inc. 52
Clinical Trial Overview of Top Institutes / Government 53
National Cancer Institute 53
Clinical Trial Overview of National Cancer Institute 53
Fred Hutchinson Cancer Research Center 65
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 65
The University of Texas M. D. Anderson Cancer Center 68
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 68
Memorial Sloan Kettering Cancer Center 70
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 70
University of Cologne 72
Clinical Trial Overview of University of Cologne 72
Children's Oncology Group 74
Clinical Trial Overview of Children's Oncology Group 74
Baylor College of Medicine 76
Clinical Trial Overview of Baylor College of Medicine 76
Stanford University 78
Clinical Trial Overview of Stanford University 78
Dana-Farber Cancer Institute, Inc. 79
Clinical Trial Overview of Dana-Farber Cancer Institute, Inc. 79
Cancer Research UK 80
Clinical Trial Overview of Cancer Research UK 80
Five Key Clinical Profiles 81
Appendix 120
Abbreviations 120
Definitions 120
Research Methodology 121
Secondary Research 121
About GlobalData 122
Contact Us 122
Disclaimer 122
Source 123

List of Tables

Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10
Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 13
Hodgkin Lymphoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 14
Hodgkin Lymphoma Therapeutics Clinical Trials, BRIC Countries, 2013* 15
Hodgkin Lymphoma Therapeutics Clinical Trials, G7 Countries, 2013* 16
Hodgkin Lymphoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Hodgkin Lymphoma Therapeutics Clinical Trials, E7 Countries, 2013* 19
Hodgkin Lymphoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
Hodgkin Lymphoma Therapeutics Market, Global, Suspended Clinical Trials, 2013* 25
Hodgkin Lymphoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 26
Hodgkin Lymphoma Therapeutics Market, Global, Terminated Clinical Trials, 2013* 27
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 33
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 35
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 37
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 38
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Genetics, Inc., 2013* 39
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2013* 41
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 43
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2013* 45
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 47
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2013* 49
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2013* 50
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 51
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2013* 52
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2013* 53
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2013* 65
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2013* 68
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2013* 70
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2013* 72
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2013* 74
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2013* 76
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2013* 78
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, Inc., 2013* 79
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Research UK, 2013* 80

List of Figures

Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10
Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 13
Hodgkin Lymphoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 14
Hodgkin Lymphoma Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
Hodgkin Lymphoma Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
Hodgkin Lymphoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Hodgkin Lymphoma Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Hodgkin Lymphoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 33
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 34
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 36
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 38
GlobalData Methodology 121